Lori Ann Santamaria
Nessuna posizione attualmente
Profilo
Lori Ann Santamaria worked as Director-Product Development at OrbusNeich Medical, Inc., Principal at Cordis Neurovascular, Inc., and Vice President-Operations at TriSalus Operating Life Sciences, Inc. She obtained an undergraduate degree from the University of Florida.
Precedenti posizioni note di Lori Ann Santamaria
| Società | Posizione | Fine |
|---|---|---|
| Cordis Neurovascular, Inc. | Corporate Officer/Principal | - |
OrbusNeich Medical, Inc.
 OrbusNeich Medical, Inc. Medical SpecialtiesHealth Technology OrbusNeich Medical, Inc. is an American company that manufactures medical instruments. Alfred J. Novak has been the CEO of the private company since 1999. | Corporate Officer/Principal | - |
TriSalus Operating Life Sciences, Inc.
 TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology TriSalus Operating Life Sciences, Inc. develops infusion systems for the interventional radiology and oncology markets. Its infusion systems are designed to deliver embolic agents through a micro-catheter with an expandable tip that collapses in forward flow and expands the vessel wall in reverse flow to increase targeted delivery, minimize reflux, and reduce damage to healthy tissue. The company was founded by Aravind Arepally and James E. Chomas in 2011 and is headquartered in Westminster, CO. | Direttore operativo | - |
Formazione di Lori Ann Santamaria
| University of Florida | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 3 |
|---|---|
OrbusNeich Medical, Inc.
OrbusNeich Medical, Inc. Medical SpecialtiesHealth Technology OrbusNeich Medical, Inc. is an American company that manufactures medical instruments. Alfred J. Novak has been the CEO of the private company since 1999. | Health Technology |
| Cordis Neurovascular, Inc. | |
TriSalus Operating Life Sciences, Inc.
TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology TriSalus Operating Life Sciences, Inc. develops infusion systems for the interventional radiology and oncology markets. Its infusion systems are designed to deliver embolic agents through a micro-catheter with an expandable tip that collapses in forward flow and expands the vessel wall in reverse flow to increase targeted delivery, minimize reflux, and reduce damage to healthy tissue. The company was founded by Aravind Arepally and James E. Chomas in 2011 and is headquartered in Westminster, CO. | Health Technology |
- Borsa valori
- Insiders
- Lori Ann Santamaria
